Other Cellular and/or Tissue Based Products (CTPs)
Last updated on 12/30/20 | First published on 12/30/20 | Literature review current through Feb. 2023
[cite]
(2020).
"Other Cellular and/or Tissue Based Products (CTPs)". In
(Eds.)
, WoundReference.
Available from: https://woundreference.com/app/topic?id=other-cellular-andor-tissue-based-products-ctps. Retrieved on 3/21/23.
Other Cellular and/or Tissue Based Products (CTPs) are not Acellular matrix, Allogeneic matrix, Composite matrix, or Human Skin Allografts but have U.S. Food and Drug Administration (FDA) clearance/approval or are designated 361 HCT/P exemption, and are used in accordance with that product’s individualized application guidelines (e.g., autologous blood clot).
Official reprint from WoundReference® woundreference.com ©2023 Wound Reference, Inc. All Rights Reserved
Use of WoundReference is subject to the
Subscription and License Agreement.
NOTE: This is a controlled document. This document is not a substitute for proper training, experience, and exercising of professional judgment. While every effort has been made to ensure the accuracy of the contents, neither the authors nor the Wound Reference, Inc. give any guarantee as to the accuracy of the information contained in them nor accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omissions in the contents of the work.
Topic 1580 Version 1.0
SUBTOPICS
ActiGraft® is an FDA-cleared regenerative wound care solution that enables health care providers to produce—in real time—in vitro blood clots from a patient’s whole blood. Once applied, the blood clot tissue serves as a protective covering, biologic scaffold and wound microenvironment to promote the natural wound healing processes of the body.ActiGraft is topically applied for the management of exuding cutaneous wounds, such as leg ulcers, p
RELATED TOPICS
Human Skin Allografts are bioengineered from human skin components and human tissue which have had intact cells removed or treated to avoid immunologic rejection.
Allogeneic Matrices are cellular and/or tissue products usually derived from human neonatal fibroblasts of the foreskin, and may contain metabolically active or regenerative components
Composite Matrices are a type of cellular and/or tissue products derived from human keratinocytes and fibroblasts supported by a scaffold of synthetic mesh or xenogeneic collagen.
Skin Substitute:Duration of ulcer - approximately 89 weeksWound free of infection, osteomyelitis, surrounding cellulitis, tunnels/tracts, necrotic tissue - yesInitial Application/Reapplication - 3rd applicationSkin substitute used - Grafix PrimeMethod of fixation - Mepitel, steristripsLot # - A160300Unit # - 16003Part # - PS60013Expiration date - 6/14/18
